← SynDRA
ADOPRAZINE
SynDRA canonical compound SYN0006500 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR1A |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor agonist
- Dopamine receptor antagonist
- HTR1A AGONIST
- Serotonin 1a (5-HT1a) receptor agonist
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- DRD3 ANTAGONIST
- Dopamine D3 receptor antagonist
- HTR1A MODULATOR
- DRD2 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD4
- HTR2A
- HTR2B
- HTR7
- CHRM1
- CHRM4
- HDAC6
- HTR2C
- HTR6
- SLC6A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Adoprazina
- SLV-313
- L001624
- RefChem:109818
- Adoprazine [INN]
- SLV313
- 7SNB18Q89D
- adoprazina
- UNII-7SNB18Q89D
- ADOPRAZINE [WHO-DD]
- SCHEMBL678503
- orb1710486
- SCHEMBL29522743
- BDBM248056
- MFCD11973649
- AKOS030526726
- CS-0673
- NCGC00378989-01
- DA-60815
- HY-14782
- MS-26938
- F84818
- T10249
- BRD-K34870043-001-01-8
- T69772
- Adoprazine monohydrochloride
- UNII-R8E4GUG6DQ
- orb1739708
- Adoprazine hydrochloride
- RefChem:199384
- R8E4GUG6DQ
- SCHEMBL4179481
- adoprazine hydrochloride
Look up ADOPRAZINE in the interactive SynDRA portal →